发表一篇学和医学成像类SCI论文
需要多少钱?
Abstract:
Identifying patients with mild cognitive impairment (MCI) who are at high risk of progressing to Alzheimer’s disease (AD) is crucial for early treatment of AD. However, it is difficult to predict the cognitive states of patients. This study developed an extreme learning machine (ELM)-based grading method to efficiently fuse multimodal data and predict MCI-to-AD conversion. First, features were extracted from magnetic resonance (MR) images, and useful features were selected using a feature selection method. Second, multiple modalities of MCI subjects, including MRI, positron emission tomography, cerebrospinal fluid biomarkers, and gene data, were individually graded using the ELM method. Finally, these grading scores calculated from different modalities were fed into a classifier to discriminate subjects with progressive MCI from those with stable MCI. The proposed approach has been validated on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort, and an accuracy of 84.7% was achieved for an AD prediction within 3 years. Experiments on predicting AD conversion from MCI within different periods showed similar results with the 3-year prediction. The experimental results demonstrate that the proposed approach benefits from the efficient fusion of four modalities, resulting in an accurate prediction of MCI-to-AD conversion.
展开更多
最新影响因子:5.702 | 期刊ISSN:1663-4365 | CiteScore:3.96 |
出版周期: | 是否OA:YES | 出版年份:0 |
期刊官方网址:http://journal.frontiersin.org/journal/aging-neuroscience
期刊投稿地址:http://www.frontiersin.org/submission/submissioninfo.aspx
自引率:7.50% | 研究方向:GERIATRICS & GERONTOLOGY-NEUROSCIENCES |
出版地区:SWITZERLAND |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
Frontiers in Aging Neuroscience is a cutting-edge multidisciplinary journal aimed at fostering the understanding of mechanistic processes associated with CNS aging and age-related neuronal diseases. Another central role of the journal is to bring cohesion between disciplines and theories focused on understanding the fundamental processes of senescence. Special emphasis is placed on integrating findings of various sub disciplines in neuroscience to yield translational insight to the aging process and neurological diseases associated with senescence, and developing treatment strategies aimed at the conservation of neuronal function. This aspect is critical to advance our ability to understand, manage, and treat conditions associated with aging. Because of the integrative nature of the journal, the scope of articles that will be considered is broad, and includes work elucidating genetic, biophysical, genomic, proteomic, cellular, molecular, biochemical, endocrinal, immunological, physiological, pharmacological, and psychological/behavioral aspects of CNS aging and neurological diseases and pathological events connected to this process. Neuroimaging studies and clinical studies targeted to mechanistic aspects of neuronal aging/disease are also welcome. Instructions for Submitting Authors For basic research involving mechanistic and intervention-based studies within the field of aging and age-related neurological diseases in animals and humans (clinical trials with neuroimaging, biomarkers for age-related disease or age-delaying interventions), please indicate in the cover letter that your submission is intended for consideration within our pre-clinical/translational division. If your manuscript involves clinical research on CNS related-related changes that occur with aging and age-related neurological diseases (changes in neurological function that occur across the lifespan or comparisons and normal aged to diseased CNS function), please indicate in the cover letter that your submission is intended for our clinical division.
《衰老神经科学前沿》是一本前沿的多学科期刊,旨在促进对中枢神经系统衰老和与年龄相关的神经疾病相关的机制过程的理解。该杂志的另一个核心作用是,将专注于理解衰老基本过程的学科和理论结合起来。特别强调整合神经科学各子学科的研究成果,对衰老过程和与衰老相关的神经系统疾病进行转化研究,并制定旨在保护神经功能的治疗策略。这方面对于提高我们理解、管理和治疗与衰老相关的疾病的能力至关重要。由于该杂志的综合性,将考虑的文章范围是广泛的,包括阐明遗传、生物物理、基因组、蛋白质组、细胞、分子、生化、内分泌、免疫学、生理学、药理学和心理/行为方面的CNS老化和神经系统疾病和病理事件与此过程相关的工作。也欢迎针对神经老化/疾病机制方面的神经影像学研究和临床研究。 提交作者须知 对于涉及动物和人类衰老和年龄相关神经系统疾病领域的机械和介入研究的基础研究(神经影像学临床试验、年龄相关疾病的生物标志物或延迟年龄干预措施),请在求职信中注明,您提交的材料将在我们的临床前/转化部门考虑。如果你的手稿包括临床研究中枢神经系统related-related发生的变化与衰老和年龄相关的神经系统疾病(神经系统功能的变化,发生在整个寿命或比较和正常年龄中枢神经系统病变的功能),请注明你提交的求职信的目的是为临床部门。
大类(学科) | 小类(学科) | 学科排名 |
医学 |
GERIATRICS & GERONTOLOGY (老年医学) 3区 NEUROSCIENCES (神经科学) 3区 |
14/53 87/261 |
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
412 | 358 | 54 |
引文计数(2018)
文献(2015-2017)
3612次引用
912篇文献
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Biochemistry, Genetics and Molecular Biology
小类(学科):Aging
|
#6/30
点击查看排名表
|
|
2 |
大类(学科):Neuroscience
小类(学科):Cognitive Neuroscience
|
#11/90
点击查看排名表
|
|
推荐刊物均可到国家新闻出
版总署网站查询正刊
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议
1对1服务,7x24小时在线
15年经验沉淀,实体公司
运营
liting7111
审稿时间: 2个月内 接受率: 中等(50%命中)
liting7111
研究方向:生命科学 神经科学 认知科学 心理学 神经生物学
审稿时间: 5个月内
liting7111
研究方向:alzheimer 神经干细胞
审稿时间: 3个月内 接受率: 中等(50%命中)
liting7111
接受率: 一般容易(75%命中)
liting7111
审稿时间: 3个月内 接受率: 一般容易(75%命中)
影响因子:2.995
ISSN:0028-3940
研究方向:医学-核医学
影响因子:2.324
ISSN:1051-2284
研究方向:医学-核医学
影响因子:3.156
ISSN:1869-1439
研究方向:CLINICAL NEUROLOGY-RADIOLOGY, NUCLEAR MEDICINE & M
影响因子:4.6
ISSN:0150-9861
研究方向:医学-核医学
影响因子:1.764
ISSN:1591-0199
研究方向:CLINICAL NEUROLOGY-RADIOLOGY, NUCLEAR MEDICINE & M
影响因子:4.966
ISSN:0195-6108
研究方向:医学-核医学
影响因子:3.005
ISSN:0301-0449
研究方向:医学-核医学
影响因子:2.396
ISSN:1793-5458
研究方向:OPTICS-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGI
影响因子:3.632
ISSN:1084-9785
研究方向:医学-核医学
发表一篇学和医学成像类SCI论文
需要多少钱?
专注医学期刊服务15年
您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:
1.医学核心期刊发表-全流程服务
2.医学SCI期刊-全流程服务
3.论文投稿服务-快速报价
4.期刊推荐直至录用,不成功不收费
客服正在输入...
Frontiers in Aging Neuroscience 投稿经验
(由下方点评分析获得,5人参与,14953人阅读)